Overview
- A securities class action is pending in the U.S. District Court for the Northern District of California under the caption Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics, No. 26-cv-07691, and several plaintiff firms have filed or are soliciting participants.
- Complaints allege PROCEPT ran an undisclosed bulk-order discount program that encouraged customers to buy handpieces in large lots, inflating reported unit sales and revenue by pulling sales from future quarters.
- Company disclosures showed U.S. handpiece shipments exceeded the number of procedures every quarter since Q1 2023 and produced cumulative excess field inventory of more than 10,000 units, a fact first revealed in the company’s Feb. 25, 2026 results.
- Investors point to a sequence of partial disclosures that drove share-price falls, including the Aug. 6, 2025 Q2 report (about a 16% drop), the Nov. 4, 2025 Q3 update (about a 10% drop), and the Feb. 25, 2026 Q4 disclosure (about an 18% two-day decline).
- Next steps include a race to be named lead plaintiff by the Sept. 22, 2026 deadline, possible consolidation of claims, discovery that will test the allegations, and potential SEC interest and recoveries for harmed shareholders if liability is proven.